By Franklin Delgado
A new study that examined the effects of omega-3 supplements on the cognitive health of older adults revealed that their consumption could be related to accelerated mental deterioration. This contradicts the long-standing judgments that place these supplements on the pedestal of health benefits for humans.
The research, published in Journal of Prevention of Alzheimer’s Diseasewhich spanned five years, analyzed 273 older adults who took omega-3s and 546 who did not, matching the groups by age and clinical profile to obtain valid results.
Subjects were evaluated with standard tools, such as MMSE and CDR-SB, revealing that those who consumed omega-3 showed a more rapid deterioration in their cognitive abilities.
Genetic and neurological factors
Despite the alarming observations, the study revealed that differences in cognitive decline are not explained by traditional Alzheimer’s factorssuch as the presence of the APOE ε4 gene.
Brain imaging indicated a decrease in glucose metabolism among omega-3 consumers, which could be related to dysfunction in neuronal communication.
Implications and recommendations
The researchers emphasize that these findings are not definitive and that the study does not establish causality. They recommend consulting with health professionals before starting any supplementation.
The results urge a reevaluation of the use of omega-3 supplements in older adults, questioning their effectiveness as a prevention strategy for cognitive decline.
How to address contradictions about supplements?
Healthcare professionals should prioritize scientific evidence and clear communication to guide patients in the face of conflicting information about supplements. This involves evaluating risks, interactions and individual needs in each consultation.
Evaluate evidence. Check reliable sources such as clinical studies in indexed journals and guidelines from agencies such as the Food and Drug Administration (FDA) or the National Institutes of Health (NIH), ruling out unsupported marketing claims. Recommend supplements only if there are deficiencies confirmed by testing, avoiding generalizations.
Discuss risks. Explain possible interactions with medications, contaminants such as heavy metals or common adulterations (e.g. sibutramine in weight loss products). Consider contraindications in patients with preexisting conditions, such as hypertension or cancer.
Foster dialogue. Ask about all the supplements the patient takes and use updated lists to review at appointments; suggest certified brands and periodic monitoring. Promote a balanced diet as opposed, clarifying that supplements do not replace proven treatments.
Use tools. Use clinical databases to check interactions and educate about lax regulations that allow products not regulated as “natural” but risky. Document advice to empower informed decisions and report adverse effects.
You may also be interested in:
· First non-antipsychotic drug approved for agitation in Alzheimer’s disease
· Researchers can achieve early detection of Alzheimer’s through voice
· With records of almost 28 million Americans, they reveal what could be the direct cause of Alzheimer’s
